These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25041947)

  • 1. A postmortem study to compare agonist and antagonist 5-HT1A receptor-binding sites in Alzheimer's disease.
    Becker G; Streichenberger N; Billard T; Newman-Tancredi A; Zimmer L
    CNS Neurosci Ther; 2014 Oct; 20(10):930-4. PubMed ID: 25041947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals.
    Vidal B; Sebti J; Verdurand M; Fieux S; Billard T; Streichenberger N; Troakes C; Newman-Tancredi A; Zimmer L
    Neuropharmacology; 2016 Oct; 109():88-95. PubMed ID: 27183968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
    Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Vidal B; Fieux S; Colom M; Billard T; Bouillot C; Barret O; Constantinescu C; Tamagnan G; Newman-Tancredi A; Zimmer L
    Brain Struct Funct; 2018 Jul; 223(6):2973-2988. PubMed ID: 29730825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease.
    Truchot L; Costes N; Zimmer L; Laurent B; Le Bars D; Thomas-Antérion C; Mercier B; Hermier M; Vighetto A; Krolak-Salmon P
    Neuroimage; 2008 Apr; 40(3):1251-6. PubMed ID: 18313943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A positron emission tomography study to assess binding of lecozotan, a novel 5-hydroxytryptamine-1A silent antagonist, to brain 5-HT1A receptors in healthy young and elderly subjects, and in patients with Alzheimer's disease.
    Raje S; Patat AA; Parks V; Schechter L; Plotka A; Paul J; Langstrom B
    Clin Pharmacol Ther; 2008 Jan; 83(1):86-96. PubMed ID: 17507923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
    J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amyloid-β peptides on the serotoninergic 5-HT1A receptors in the rat hippocampus.
    Verdurand M; Bérod A; Le Bars D; Zimmer L
    Neurobiol Aging; 2011 Jan; 32(1):103-14. PubMed ID: 19249128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study.
    Lothe A; Boni C; Costes N; Bouvard S; Gorwood P; Lavenne F; Alvarez M; Ryvlin P
    Behav Brain Funct; 2010 Jul; 6():37. PubMed ID: 20609217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain.
    Shrestha SS; Liow JS; Lu S; Jenko K; Gladding RL; Svenningsson P; Morse CL; Zoghbi SS; Pike VW; Innis RB
    J Nucl Med; 2014 Jan; 55(1):141-6. PubMed ID: 24385311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans.
    Mukherjee J; Bajwa AK; Wooten DW; Hillmer AT; Pan ML; Pandey SK; Saigal N; Christian BT
    J Comp Neurol; 2016 May; 524(7):1457-71. PubMed ID: 26509362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward brain imaging of serotonin 5-HT1A autoreceptor internalization.
    Zimmer L; Riad M; Rbah L; Belkacem-Kahlouli A; Le Bars D; Renaud B; Descarries L
    Neuroimage; 2004 Jul; 22(3):1421-6. PubMed ID: 15219613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study.
    Lothe A; Didelot A; Hammers A; Costes N; Saoud M; Gilliam F; Ryvlin P
    Brain; 2008 Oct; 131(Pt 10):2765-82. PubMed ID: 18765418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective 5-HT1a receptor agonist improves respiration in a mouse model of Rett syndrome.
    Levitt ES; Hunnicutt BJ; Knopp SJ; Williams JT; Bissonnette JM
    J Appl Physiol (1985); 2013 Dec; 115(11):1626-33. PubMed ID: 24092697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.
    Mizukami K; Ishikawa M; Akatsu H; Abrahamson EE; Ikonomovic MD; Asada T
    Neuropathology; 2011 Oct; 31(5):503-9. PubMed ID: 21269332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder.
    Stockmeier CA; Howley E; Shi X; Sobanska A; Clarke G; Friedman L; Rajkowska G
    J Psychiatr Res; 2009 Jul; 43(10):887-94. PubMed ID: 19215942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.
    Lladó-Pelfort L; Assié MB; Newman-Tancredi A; Artigas F; Celada P
    Br J Pharmacol; 2010 Aug; 160(8):1929-40. PubMed ID: 20649591
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.